426
M. V. Pavlova et al.
cipitated product was separated by filtration and recry-
stallized from ethanol; 1H NMR spectrum (d, ppm):
6.08 – 6.31 (d, 1H, NH-alkylamide) or 10.22 – 10.36 (s, 1H,
NH-arylamide), 7.02 – 8.46 (m, ArH).
EXPERIMENTAL BIOLOGICAL PART
The antiinflammatory activity of the synthesized com-
pounds (Ia – Ij, IIa – IIg, IIIa – IIIe), 2-chloroisonicotinic
acid, and 2-chlorocinchoninic acid was studied on white
mongrel rats weighing 150 – 220 g bearing a foot edema
model [8] induced by subplantar injections of 0.1 ml of a 1%
carrageenan solution into the hind paws of the test animals.
The compounds to be tested (in a dose of 50 mg/kg) and the
reference drug ortophen (10 or 25 mg/kg) were intraperito-
neally injected 1 h prior to carrageenan. The edema growth
was evaluated oncometrically, by measuring the inflamed
foot volume 3 and 5 h after carrageenan injection [8], and ex-
pressed as percentage edema growth inhibition relative to
control. The experimental data were statistically processed in
terms of the Student t-criterion [9].
2-Chloroisonicotinic acid aryl esters (Ie – Ij). To
1.57 g (0.01 mole) of 2-chloroisonicotinic acid was added
30 ml of thionyl chloride and the mixture was boiled for 1 h,
after which the excess thionyl chloride was distilled off at re-
duced pressure. The residue was dissolved in 20 ml of ben-
zene. To this solution was added 0.01 mole of the corre-
sponding phenol in 50 ml of the same solvent and 0.01 mole
of triethylamine and the mixture was heated for 1 h on a wa-
ter bath. Then the benzene was distilled off and the residue
was treated with a 10% sodium hydrocarbonate solution. The
precipitated product was separated by filtration and
1
recrystallized from ethanol; H NMR spectrum (d, ppm):
6.75 – 8.58 (m, ArH).
It was found that 2-chloroisonicotinic acid administered
in a dose of 50 mg/kg inhibits the carrageenan edema
growth: by 61.2% after 3 h and by 59.4% after 5 h. Among
the 2-chloroisonicotinic acid aryl esters and amides (Ia – Ij),
a reliable antiinflammatory effect was observed only for
compound Ih which, in the same dose of 50 mg/kg, inhibited
the edema growth by 57.3 and 52.3% after 3 and 5 h, respec-
tively (thus being inferior to ortophen).
2-Chlorocinchoninic acid aryl esters (IIa – IIg). To
2.07 g (0.01 mole) of 2-chlorocinchoninic acid was added
30 ml of thionyl chloride and the mixture was boiled for 1 h,
after which the excess thionyl chloride was distilled off at re-
duced pressure. The residue was dissolved in 20 ml of ben-
zene. To this solution was added 0.01 mole of the corre-
sponding phenol in 50 ml of the same solvent and 0.01 mole
of triethylamine and the mixture was heated for 1 h on a wa-
ter bath. Then benzene was distilled off and the residue was
treated with a 10% sodium hydrocarbonate solution. The pre-
cipitated product was separated by filtration and recry-
stallized from isopropyl alcohol; 1H NMR spectrum (d,
ppm): 6.83 – 8.95 (m, ArH).
2-Chlorocinchoninic acid in a dose of 50 mg/kg inhibits
the carrageenan edema growth by 45.3 and 41.6% after 3 and
5 h, respectively. Among the aryl esters of 2-chloro- and
2-oxocinchoninic acids, a reliable antiinflammatory effect
was observed only for compounds IIa, IIb, IIIa, IIIb, and IIIe
(Table 2).
2-Oxo-1,2-dihydrocinchoninic acid esters (IIIa – IIIe).
A mixture of 0.01 mole of 2-chlorocinchoninic acid ester and
1.2 g (0.015 mole) sodium acetate in 10 ml of concentrated
acetic acid was boiled for 1 h, cooled, and diluted with water.
The precipitated product was separated by filtration and
TABLE 2. Yields, Physicochemical Characteristics, and Antiinf-
lammatory Activity of Compounds IIa – IIg and IIIa – IIIe
1
recrystallized from dioxane; H NMR spectrum (d, ppm):
12.21 – 12.42 (bs, 1H, NH rings), 6.95 – 8.48 (m, ArH).
Edema growth
inhibition,
Com- Yield,
pound
M.p.,
°C
Empirical
formula
Dose,
% of control
%
mg/kg
3 h 5 h
IIa
83 160 – 161 C16H9BrClNO2 50
20.3* 26.2*
IIb
81 124 – 125 C16H9ClFNO2
79 125 – 126 C17H12ClNO2
81 125 – 127 C17H12ClNO3
72 120 – 122 C18H12ClNO3
75 129 – 131 C18H12ClNO4
64 194 – 196 C18H13ClN2O3
91 260 – 262 C16H10BrNO3
83 228 – 229 C17H13NO3
78 238 – 240 C17H13NO4
85 243 – 244 C18H13NO4
87 228 – 230 C18H13NO5
50
50
…
…
50
50
27.6** 34.0***
IIc
–
…
…
–
–
…
…
–
TABLE 1. Yields and Physicochemical Characteristics of Com-
pounds Ia – Ij
IId
IIe
Compound
Yield, %
M.p., °C
Empirical formula
IIf
Ia
Ib
Ic
Id
Ie
If
73
76
79
77
85
83
79
77
81
76
104 – 105
105 – 106
131 – 132
144 – 145
80 – 81
80 – 81
79 – 80
C9H11ClN2O
C10H13ClN2O
C12H8Cl2N2O
C12H8Cl2N2O
C12H7BrClNO2
C13H10ClNO2
C13H10ClNO3
C14H10ClNO3
C14H10ClNO4
C14H11ClN2O3
IIg
–
–
IIIa
IIIb
IIIc
IIId
IIIe
Ortophen
50 43.6** 39.5***
50
…
…
22.0*
22.3*
…
…
…
…
50 49.0*** 44.4***
25 69.4*** 72.2***
Ig
Ih
Ii
63
10 55.4**
…
80 – 81
Ij
166 – 167
Notes: * p > 0.05, ** p < 0.05, *** p < 0.001 relative to control.